<< Back to Chemical Sampling Information
|
Chemical Sampling Information (CSI)
|
|
|
| Search (use word(s)/phrase) |
|
|
|
Table of Contents
|
|
|
|
|
|
|
Quick Links
|
|
|
|
|
Silver, Metal and Soluble Compounds (as Ag)
Synonyms:
- Silver metal: Argentum
- Soluble silver compounds: Vary depending upon the specific compound, such as silver nitrate (AgNO3)
OSHA IMIS Code Number: 2240
Chemical Abstracts Service (CAS) Registry Number: 7440-22-4 (metal)
NIOSH Registry of Toxic Effects (RTECS) Identification Number: VW3500000
NIOSH Pocket Guide to Chemical Hazards - Silver (metal dust and soluble compounds, as Ag): Physical description, chemical properties, potentially hazardous incompatibilities, and more
Exposure Limit |
Limit Values |
HE Codes |
Health Factors and Target Organs |
OSHA Permissible Exposure Limit (PEL) - General Industry
See 29 CFR 1910.1000 Table Z-1 |
0.01 mg/m3 TWA |
HE3 |
Argyria* |
OSHA PEL - Construction Industry
See 29 CFR 1926.55 Appendix A |
0.01 mg/m3 TWA |
HE3 |
Argyria* |
OSHA PEL - Shipyard Employment
See 29 CFR 1915.1000 Table Z-Shipyards |
0.01 mg/m3 TWA |
HE3 |
Argyria* |
National Institute for Occupational Safety and Health (NIOSH) Recommended Exposure Limit (REL) |
0.01 mg/m3 TWA |
HE3 |
Argyria* |
HE4 |
Eye and skin burns |
HE14 |
Eye and skin irritation |
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value (TLV) (2001) |
Metal dust:
0.1 mg/m3 TWA
Soluble compounds:
0.01 mg/m3 TWA |
HE3 |
Argyria* |
CAL/OSHA PELs |
Metal:
0.01 mg/m3 TWA
Soluble compounds:
0.01 mg/m3 TWA |
|
|
* Argyria is a permanent blue-gray discoloration of the skin, mucous membranes, and/or the eyes as a result of silver exposure.
National Toxicology Program (NTP) carcinogenic classification: Not listed
International Agency for Research on Cancer (IARC) carcinogenic classification: Not listed
U.S. Environmental Protection Agency (EPA) carcinogenic classification: Not classifiable as to human carcinogenicity
EPA Inhalation Reference Concentration (RfC): Not established
Agency for Toxic Substances and Disease Registry (ATSDR) Inhalation Minimal Risk Level (MRL): Not established
NIOSH Immediately Dangerous to Life or Health (IDLH) concentration: 10 mg/m3 (as Ag)
Notes on Other Potential Health Effects and Hazards
- EPA's oral reference dose (RfD) for silver is 0.005 mg/kg/day (EPA 1996).
- While metallic silver appears to pose minimal risk to human health, soluble silver compounds may cause liver and kidney damage as well as changes in blood cells (Drake and Hazelwood 2005).
- Biological monitoring of different types of occupational exposure to silver by determining silver levels in whole blood found the highest levels in those working in silver reclamation (Armitage et al. 1996).
- Silver can be permanently deposited in connective tissue as silver metal, silver sulfide, or selenide to produce a slate-gray appearance (Drake and Hazelwood 2005).
- OSHA has had cases (e.g., precious metal refining facility, specialty battery manufacturer) involving worker overexposure to silver (Rosa 2004). Other reported cases have involved silver solderers in Mexico (Sanchez-Huerta et al. 2003) and a silver polisher in England (Kayarkar et al. 2003).
- Exposure to very high concentrations of silver may result in diffuse pulmonary fibrosis, visible on chest radiograms (ACGIH 2001).
- There is an increasing use of silver nanoparticles in many industries, and there is some evidence that suggests these nanoparticles could be cytotoxic. Exposure to silver nanoparticles may induce oxidative stress (Wasowicz et al. 2011) as well as cause DNA adducts and damage (Foldbjerg et al. 2011).
Date Last Revised: 9/6/2012
Literature Basis
- ACGIH: Documentation of the Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) - Silver and Compounds. 2001.
- Armitage, S.A., White, M.A. and Wilson, H.K.: The determination of silver in whole blood and its application to biological monitoring of occupationally exposed groups. Ann. Occup. Hyg. 40(3): 331-338, 1996.
- Drake, P.L. and Hazelwood, K.J.: Exposure-related health effects of silver and silver compounds: a review. Ann. Occup. Hyg. June 17, 2005.
- EPA: IRIS - Silver (CASRN 7440-22-4). December 1, 1996.
- Foldbjerg, R., Dang, DA., Autrup, H.: Cytotoxicity and genotoxicity of silver nanoparticles in the human lung cancer cell line, A549. Arch Toxicol. 85(7): 743-750, 2011.
- Kayarkar, R., Parker, A.J. and Geopel, J.R.: The Sheffield nose - an occupational disease? Rhinology 41(2): 125-126, 2003.
- NIOSH/IPCS: International Chemical Safety Cards - Silver. September 10, 1997.
- NIOSH: Occupational Health Guideline - Silver Metal and Soluble Silver Compounds. September 1978.
- Rosa, C.: OSHA compliance issues. Overexposure to silver on a programmed lead inspection. J. Occup. Environ. Hyg. 1(9): D93-95, 2004.
- Sanchez-Huerta, V., De Wit-Carter, G., Hernandez-Quintela, E. and Naranjo-Tackman, R.: Occupational corneal argyrosis in art silver solderers. Cornea 22(7): 604-611, 2003.
- Wasowicz, W. et al.: Evaluation of biological effects of nanomaterials. Part I. Cyto- and genotoxicity of nanosilver composites applied in textile technologies. Int J Occup Med Environ Health. 24(4): 248-358, 2011.
Laboratory Sampling/Analytical Method:
- sampling media: Mixed Cellulose Ester Filter (MCEF) 0.8 microns
maximum volume: 960 Liters
minimum volume: 480 Liters
maximum flow rate: 2.0 L/min
current analytical method: Atomic Absorption Spectroscopy; AAS
method reference: OSHA Analytical Method (OSHA ID-121)
method classification: Fully Validated
alternate analytical method: Inductively Coupled Argon Plasma; ICP/DCP-AES
method reference: OSHA Analytical Method (OSHA ID-206)
method classification: Fully Validated
note: If the filter is not overloaded, samples may be collected up to an 8-hour period.
** All Trademarks are the property of their respective owners.
|